Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-wen Tang

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Zhonghua Nei Ke Za Zhi|April 3, 2004
[Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation]Xiao-wen Tang, De-pei Wu, Xue-ming Xia, et al.
Zhonghua Nei Ke Za Zhi|June 20, 2006
[Quantitative analysis of donor chimerism in adoptive immunotherapy following allogeneic hematopoietic stem cell transplantation]Xiao-wen Tang, De-pei Wu, Ai-ning Sun, et al.
Oncotargets and Therapy|November 8, 2021
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell TransplantationXin-Yue Zhang, Hai-Ping Dai, Ling Zhang, et al.
Acta Pharmacologica Sinica|August 9, 2016
Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responsesQiao-Ling Yang, Fan Yang, Jun-Ting Gong, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 24, 2003
[Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies]De-pei Wu, Xiao-wen Tang, Ai-ning Sun, et al.
Yi Chuan = Hereditas|October 22, 2008
[Mitochondrial tRNAThr G15927A mutation may influence the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation.]Xiao-Wen Tang, Zhi-Yuan Li, Jian-Xin Lu, et al.
Hematological Oncology|April 26, 2013
Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patientsSheng-Li Xue, Hong-Xia Cui, Jing-Ying Zou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 3, 2013
[Efficacy analysis of unrelated donor hematopoietic stem cell transplantation for treatment of high risk acute myeloid leukemia]Fan Ye, Xiao-Wen Tang, Ai-Ning Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 11, 2021
[The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases]Yuan-Ling Zuo, Ju-Ping Zhai, Yong Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 23, 2020
[Ikaros Family Zinc Finger 1 Mutation Is an Adverse Prognostic Factor for Patients with Adult B-Cell Acute Lymphoblastic Leukemia]Shan-Hao Tang, Ying Lu, Pi-Sheng Zhang, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Zhonghua Nei Ke Za Zhi|April 3, 2004
[Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation]Xiao-wen Tang, De-pei Wu, Xue-ming Xia, et al.
Zhonghua Nei Ke Za Zhi|June 20, 2006
[Quantitative analysis of donor chimerism in adoptive immunotherapy following allogeneic hematopoietic stem cell transplantation]Xiao-wen Tang, De-pei Wu, Ai-ning Sun, et al.
Oncotargets and Therapy|November 8, 2021
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell TransplantationXin-Yue Zhang, Hai-Ping Dai, Ling Zhang, et al.
Acta Pharmacologica Sinica|August 9, 2016
Sweroside ameliorates α-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responsesQiao-Ling Yang, Fan Yang, Jun-Ting Gong, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 24, 2003
[Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies]De-pei Wu, Xiao-wen Tang, Ai-ning Sun, et al.
Yi Chuan = Hereditas|October 22, 2008
[Mitochondrial tRNAThr G15927A mutation may influence the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation.]Xiao-Wen Tang, Zhi-Yuan Li, Jian-Xin Lu, et al.
Hematological Oncology|April 26, 2013
Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patientsSheng-Li Xue, Hong-Xia Cui, Jing-Ying Zou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 3, 2013
[Efficacy analysis of unrelated donor hematopoietic stem cell transplantation for treatment of high risk acute myeloid leukemia]Fan Ye, Xiao-Wen Tang, Ai-Ning Sun, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 11, 2021
[The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases]Yuan-Ling Zuo, Ju-Ping Zhai, Yong Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 23, 2020
[Ikaros Family Zinc Finger 1 Mutation Is an Adverse Prognostic Factor for Patients with Adult B-Cell Acute Lymphoblastic Leukemia]Shan-Hao Tang, Ying Lu, Pi-Sheng Zhang, et al.
Pageof 9